Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yunchao Xin, Xiaoling Shang, Xiaoran Sun, Guogang Xu, Yachao Liu & Yanbin Liu. (2022) SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis. Bioengineered 13:5, pages 12572-12582.
Read now
Read now
Mengyuan Li, Hongwei Jiang, Shengjiang Chen & Yujin Ma. (2022) GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma. Bioengineered 13:4, pages 11336-11357.
Read now
Read now
Articles from other publishers (3)
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, Timo L.M. ten Hagen, Shokooh Salimimoghadam, Afshin Taheriazam, Maliheh Entezari & Mojtaba Falahati. (2023) HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response. Pharmacological Research 190, pages 106732.
Crossref
Crossref
Vahid Asghariazar, Behzad Mansoori, Mahtab Kadkhodayi, Elham Safarzadeh, Ali Mohammadi, Behzad Baradaran & Ebrahim Sakhinia. (2022) MicroRNA-143 act as a tumor suppressor microRNA in human lung cancer cells by inhibiting cell proliferation, invasion, and migration. Molecular Biology Reports 49:8, pages 7637-7647.
Crossref
Crossref
Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, Suvrendu Sankar Kar & Sandeep Kumar Dash. (2022) Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation. Current Research in Pharmacology and Drug Discovery 3, pages 100131.
Crossref
Crossref